09.20.23 -- ARPA-H NITRO: An Osteoarthritis Cure Rocket Fuel Or TNT?

As precision medicine advances, discover how the timing of rare disorder diagnosis could be improved so that treatment can begin at earlier stages of the illness.

Nonstatistical team members are encouraged to read this summary regarding the FDA’s guidance to better understand and support covariate adjustments applied in clinical trials.

Unearth how Medidata Trial Design was able to utilize historical trial data and real-life examples across different indications throughout the clinical development process in five case studies.

Advancing to clinical trials is an exciting milestone in drug development — but it can also be daunting. Arm your team with important factors to consider by exploring this infographic.

Watch as speakers review immunotherapy, discuss a range of current and developing approaches, and explore the unique challenges that the new treatment options present in a clinical trial setting.

Embark on a journey to uncover six compelling reasons behind adopting this RTSM solution, which boasts a modern front-end interface, for your upcoming study.

Speed solutions combine value-added services and expertise, delivering an integrated approach, de-risking the supply chain by eliminating the need to transfer to alternative suppliers.

With over 20 years of experience, Altasciences’ pain experts and neuroscientists are here to guide the most appropriate pain model selection for evaluating the efficacy and safety profile of your study drug.

Across the pharmaceutical industry, clinical research sites face many challenges. Individual sites vary widely and need flexible, tailor-made solutions that can evolve and adapt to their unique needs.

Social determinants of health are among the reasons for low participation in clinical trials among minority communities. This is an area in which home research nurses can make a significant positive impact.